Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges
Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 863-879
DOI: 10.1111/jgh.70245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 02.02.2026. Verfasst von Husni Farah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Exosomes, Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 187 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) remains one of the most prevalent and lethal malignancies worldwide, characterized by late diagnosis, limited therapeutic options, and poor prognosis. Conventional systemic therapies such as sorafenib and its successors provide only modest survival benefits and are frequently complicated by toxicity and drug resistance. In recent years, immunotherapy has emerged as a promising avenue, yet its efficacy is often restricted by the profoundly immunosuppressive tumor microenvironment (TME). Within this landscape, exosomes—nanoscale extracellular vesicles secreted by tumor, stromal, and immune cells—have gained increasing attention for their central role in intercellular communication. They influence immune modulation, metabolic reprogramming, and therapeutic resistance, while also serving as potential biomarkers, nanocarriers, and vaccine platforms. Tumor‐derived exosomes (TEXs) contribute to immune evasion by suppressing CD8 + T cells, polarizing macrophages toward protumoral phenotypes, and enhancing immune checkpoint resistance. Conversely, engineered exosomes demonstrate significant therapeutic potential by reprogramming TAMs, improving drug delivery, and acting as cancer vaccines. Despite these advances, challenges remain in exosome biogenesis, heterogeneity, large‐scale production, and off‐target effects, which hinder clinical translation. Furthermore, interactions between exosomes and gut microbiota in modulating hepatic immunity represent an emerging frontier with unexplored therapeutic implications. Continued advances in bioengineering, nanotechnology, and systems biology are expected to refine exosome‐based therapies, offering novel, personalized strategies to improve outcomes for HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
- College of Pharmacy, Islamic University, Najaf, Iraq.
- College of Pharmacy, Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.
- Department of Medicinal Chemistry, Al-Turath University, Baghdad, Iraq.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Department of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
ORCID-Profile: Priya Priyadarshini-Nayak
Zitieren
APA
Farah, H., Kadhim-Abosaoda, M., Mohaisen-Mousa, H., Jyothi, R., Priyadarshini-Nayak, P., Janney-J, B., Singh, G., Singh-Chauhan, A., & Kumar-Mishra, M. (2026). Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges. Journal of Gastroenterology and Hepatology, 41(3), 863-879. https://doi.org/10.1111/jgh.70245
Vancouver
Farah H, Kadhim-Abosaoda M, Mohaisen-Mousa H, Jyothi R, Priyadarshini-Nayak P, Janney-J B, et al. Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges. Journal of Gastroenterology and Hepatology. 2026;41(3):863-879. doi:10.1111/jgh.70245
BibTeX
@article{Farah2026,
author = {Farah, Husni and Kadhim-Abosaoda, Munthar and Mohaisen-Mousa, Hayjaa and Jyothi, Renuka and Priyadarshini-Nayak, Priya and Janney-J, Bethanney and Singh, Gurjant and Singh-Chauhan, Ashish and Kumar-Mishra, Manoj},
title = {Exosome‐Based Strategies in Hepatocellular Carcinoma: Mechanisms, Immunotherapy, and Clinical Challenges},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {3},
pages = {863--879},
doi = {10.1111/jgh.70245}
}
EUVIMED